Skip to main content

Table 1 BRCA screening by ethnicity

From: Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2

 

West Eur

Cent Eur

Latin Am

African

Asian

Nat Am

Mid East

All

BRCA1

2501

336

185

180

75

44

30

3351

BRCA2

1899

214

105

100

75

35

16

2444

Total mutant

4400

550

290

280

150

79

46

5795

Subjects

36235

4066

1936

1767

1183

597

492

46276

% Mutation

12 %

14 %

15 %

16 %

13 %

13 %

9 %

13 %

Ratio BRCA1/2

1.32

1.57

1.76

1.80

1.00

1.26

1.88

1.37

% Sample

78 %

9 %

4 %

4 %

3 %

1 %

1 %

 

US pop (1000s)

196817

 

50477

37686

14465

2247

  

Screened/100,000

18.4

 

3.84

4.69

8.18

   

Ratio West Eur/minority

 

4.80

3.93

2.25

   
  1. Data from Hall et al. [17] on BRCA screening and mutations identified by ethnic group were used to calculate the ratio of BRCA1/BRCA2 mutations (ratio BRCA1/2), and the percentage of the total sample represented by that ethnicity (% sample). The size of selected ethnic groups according to the US Census in thousands (US Pop (1000s)) divided by the number of subjects yields the number screened per 100,000 (Screened/100,000). The ratio of Western Europeans (West Eur) screened to Latin Americans (Latin Am), African Americans (African), and Asian American (Asians) was calculated by dividing Screened/100,000 for West Eur (18.4) by the corresponding figure of the minority population (Ratio West Eur/minority). Including the Central European (Cent Eur) women in with the West Eur women raises the minority ratios slightly (not shown)